|
|
|||
| Genetic risk
factors are involved in the predisposition of individuals to venous thrombosis.
These factors include inherited resistance to activated protein C (APC)
as well as deficiencies in antithrombin III, protein C and protein S.
APC resistance is a major basis for familial thrombosis and is common
in the general population (2-5%). APC resistance is frequently associated
with factor V Leiden, a point mutation in the factor V gene. Individuals
heterozygous for this mutation have an increased risk for venous thrombosis
(approximately 5- to 10-fold). Individuals homozygous for this mutation
have an even higher risk for venous thrombosis (approximately 50- to 100-fold).
Prophylactic anticoagulation therapy should be considered for carrier
individuals at risk in situations where venous stasis is likely (i.e.
prolonged bed rest after surgery). Reasons for Referral:
Testing Methodology:Direct Mutation Analysis: Our laboratory uses DNA amplification (PCR) and an automated mini-sequencing methodology, Pyrosequencing, to test for the R506Q mutation in the Factor V gene. Sensitivity:Approximately 90% of APC-resistance is due to Factor V Leiden. Specimen Requirements:Blood: EDTA (purple-top) tubes: Adults: 14
cc; Child: 6
cc; Infant: 2-3 cc Turnaround Time:2 weeks CPT Codes and Prices:83914, 83912, 83898, 83891 Shipping InformationForms:Test Code:6028 |